Atlas Trials

An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC

Clinical trial NCT06839989 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06839989
Sponsor
Institute of Tropical Medicine, Belgium
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Mpox (Monkeypox)
Start date
2025-08-04
Primary completion
2026-05-20
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.